A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province

Last updated: January 15, 2020
Sponsor: Xijing Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Premature Ejaculation

Treatment

N/A

Clinical Study ID

NCT04235192
4222018004
  • Ages 18-64
  • Male
  • Accepts Healthy Volunteers

Study Summary

Through a multicenter case-control study on the risk factors of premature ejaculation in Shaanxi, to find out the related factors of the occurrence and development of premature ejaculation, to provide reference for personalized treatment, in order to improve the quality of sexual life of patients and partners.

Eligibility Criteria

Inclusion

Inclusion Criteria:

    1. case group
  1. 18-64 years old, regular sexual life > 6 months;

  2. Self-report of premature ejaculation;

  3. Able to complete questionnaires and scale scores independently. 2) control group

  4. 18-64 years old, regular sexual life > 6 months;

  5. Both partners are satisfied with their sexual life;

  6. Able to complete questionnaires and scale scores independently.

Exclusion

Exclusion Criteria:

    1. case group
  1. Those who are unable to have sex due to genital malformation;

  2. Patients with serious cardiovascular and cerebrovascular diseases;

  3. Severe mental disorders (history of epilepsy, mania, etc.);

  4. Have a history of brain trauma;

  5. People with a long history of substance abuse. 2) control group

  6. Patients with a history of mental illness;

  7. Oral selective serotonin (5-ht) reuptake inhibitors, tricyclic antidepressants,triazolidine antidepressants, tramadol and sedatives

Study Design

Total Participants: 1340
Study Start date:
July 31, 2019
Estimated Completion Date:
October 01, 2020

Connect with a study center

  • Xijing Hospital, Fourth Military Medical University

    Xi'an, Shaanxi 710032
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.